本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ensysce Biosciences Inc.

3.05
+0.0000
成交量:9.56万
成交额:28.31万
市值:501.64万
市盈率:-0.27
高:3.10
开:2.95
低:2.87
收:3.05
数据加载中...
2022/05/05

重要事件披露

8-K - Current report
2022/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/31

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/08

重要事件披露

8-K - Current report
2022/01/31

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/27

重要事件披露

8-K - Current report
2022/01/18

重要事件披露

8-K - Current report
2021/12/27

重要事件披露

8-K - Current report
2021/11/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/29

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/25

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/10/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/07

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/09/27

重要事件披露

8-K - Current report
2021/09/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/17

重要事件披露

8-K - Current report
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]